JW Holdings Corporation (KRX:096760)
3,585.00
+80.00 (2.28%)
At close: Jun 2, 2025, 3:30 PM KST
JW Holdings Revenue
JW Holdings had revenue of 239.53B KRW in the quarter ending March 31, 2025, with 7.42% growth. This brings the company's revenue in the last twelve months to 904.26B, down -3.25% year-over-year. In the year 2024, JW Holdings had annual revenue of 887.71B, down -4.35%.
Revenue (ttm)
904.26B
Revenue Growth
-3.25%
P/S Ratio
0.29
Revenue / Employee
6.85B
Employees
132
Market Cap
259.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 887.71B | -40.36B | -4.35% |
Dec 31, 2023 | 928.07B | 63.54B | 7.35% |
Dec 31, 2022 | 864.54B | 75.60B | 9.58% |
Dec 31, 2021 | 788.94B | 7.42B | 0.95% |
Dec 31, 2020 | 781.51B | 53.43B | 7.34% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 4.30B |
PharmaResearch | 392.31B |